Articles On Avita Medical (ASX:AVH)

Title Source Codes Date
ASX Market Close: Local bourse manages last gasp of green cheer heading into Chrissy shutdown | Dec 24, 2024

The ASX 200 ended on a positive closing note before Santa’s arrival (a fair bit) later this evening with a 0.29% gain, adding a short 24 points to 8,217. Real Estate was today’s top sector leader, ending the day up 0.82%, followed by Hea...

themarketonline.com.au AVH 9 hours ago
Why Avita Medical, GenusPlus, Mesoblast, and Polynovo shares are storming higher

The S&P/ASX 200 Index (ASX: XJO) is having a volatile session but is currently on course to record a small gain. In early afternoon trade, the benchmark index is up slightly to 8,208.5 points. Four ASX shares that are rising more than m...

Motley Fool AVH 12 hours ago
Leading brokers name 3 ASX shares to buy today

With so many shares to choose from on the Australian share market, it can be difficult to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you. Three top ASX shares that leading...

Motley Fool AVH 13 hours ago
Guess which ASX healthcare stock is jumping 7% on US FDA approval news

AVITA Medical Inc (ASX: AVH) shares are having a strong start to the day. In morning trade, the ASX healthcare stock is up over 7% to $4.10. Why is this ASX healthcare stock jumping? Investors have been buying the regenerative medicine comp...

Motley Fool AVH 14 hours ago
ASX Market Open: Short trade day for Chrissy Eve to barely stay green after yesterday’s rocket run | Dec 24, 2024

The ASX 200 is expected to stay ever so slightly in the green at open on Christmas Eve after the Wall Street Santa rush (mostly) ploughed on through weaker-than-expected U.S. consumer confidence reported on Monday. The Magnificent Seven...

themarketonline.com.au AVH 16 hours ago
Stocking stuffers: Morgans’ top ASX health picks for 2025

Morgans sees opportunities among several ASX healthcare stocks in 2025 Broker looking at stocks with near-term catalysts or sold down with good entry opportunities Morgans’ Christmas stocking has mix of up-and-comers alongside mature names...

Stockhead AVH 1 day ago
Health Check: Can Syntara produce the next multibillion-dollar Aussie blood cancer drug?

Syntara aims for FDA ‘breakthrough’ therapy status for its myelofibrosis drug candidate FAK! More promising results from Amplia’s pancreatic cancer trial Oh, you shouldn’t have! Broker Morgans’ Christmas biotech hamper   Armed with encour...

Stockhead AVH 1 week ago
Dr Boreham’s Crucible: ‘The sun is coming up’ for this skin-regeneration specialist

When it comes to medical devices, improving the lives of clinicians is just as important as improving the lives of patients. If both these aims can be achieved, that’s the sweet spot. In the case of Avita Medical (ASX:AVH), the company’s ap...

Stockhead AVH 2 weeks ago
ASX November Health Winners: Paradigm, Imricor lead sector as momentum returns

The S&P/ASX 200 Health Care Index rose 2.89% in November as momentum returned to the sector Health cryogenic services company Vitrafy and nerve-repair biotech Renerve debuted on the ASX  Paradigm Biopharmaceuticals rose 151% in Novembe...

Stockhead AVH 2 weeks ago
Scott Power: S&P/ASX 200 Health Care Index falls but which stocks are up on positive news?

ASX health stocks fall 1.3% in past five days, while broader market is marginally up 0.7%  Neuren soars on sale of priority review voucher and $50 million share buyback Neurizon releases positive preclinical results on lead drug candidate...

Stockhead AVH 1 month ago
Health Check: Could the White House be about to welcome LSD and magic mushrooms into the Oval Office?

Emyria says the Trump administration’s expected liberalisation of psychedelic therapies was the likely reason for yesterday’s 42% share spurt  Avita Medical brings it home with an Aussie distribution deal  EBR System expects US approval fo...

Stockhead AVH 1 month ago
3 exciting small cap ASX shares to buy in November

If you are a fan of small cap ASX shares, then you will be pleased to know that analysts have recently named a number as buys. Here's what you need to know about these shares from the small side of the market: AVITA Medical Inc (ASX: AVH)...

Motley Fool AVH 1 month ago
Five ASX healthcare companies poised for game-changing catalysts

Several ASX healthcare companies have upcoming catalysts, which can be a focal point for healthcare investors Dimerix forecasts the second interim analysis of its ACTION 3 global phase III trial of DMX-200 to treat FSGS in around mid-CY25...

Stockhead AVH 1 month ago
ASX Market Close: IT stocks lead bourse higher | November 8, 2024

The ASX200 closed 0.84% at 8,295 points. The market remains buoyant in the wake of Trump’s election in the United States, and the expectation China will ramp up stimulus measures. IT finished the session the best performing sector, up...

themarketonline.com.au AVH 1 month ago
RECELL boosts revenue, but AVITA feels the burn

AVITA Medical (Nasdaq: RCEL, ASX: AVH), a leader in regenerative medicine with its proprietary RECELL technology, reported a substantial increase in revenue for the third quarter ended 30 September 2024. The company recorded commercial reve...

ShareCafe AVH 1 month ago
October Health Winners: Uscom, Respiri lead sluggish sector, but ‘time in the market, not timing, is key’

ASX healthcare stocks underperform but optimism grows Uscom, Respiri and Hitiq report mixed results Artrya and Nyrada make key clinical advances   The S&P/ASX 200 Health Care [XHJ] index was down 0.9% gain in October. For the year, th...

Stockhead AVH 1 month ago
Scott Power: Which company dropped 30pc on its latest quarterly result?

ASX health stocks fall 2.15% in past five days, while broader market down 1.42%  MedAdvisor drops 30% on latest quarterly result as MicroX and Mach 7 also fall Micro X reports a ‘ho-hum’ results, while AGMs so far remain rather uneventful ...

Stockhead AVH 1 month ago
These small cap ASX shares could rise 25% to 100%

Investors that are looking for exposure to the small side of the market, might want to check out the small cap ASX shares listed below. That's because they were recently named as buys by brokers and tipped to rise strongly from current leve...

Motley Fool AVH 2 months ago
September
Health Winners: EZZ and Althea lead upbeat sector sparked by Fed rate cut

Healthcare stocks are doing relatively well globally in 2024
 The sector could see more recovery as Fed cuts rates
 How ASX biotechs performed in the month of September   The S&P 500 Health Care Index, a key world benchmark for health...

Stockhead AVH 2 months ago
Buy these small cap ASX shares before interest rates fall

Many analysts believe that interest rate cuts will put a rocket under small cap ASX shares, which have been underperforming during the rate hike cycle. And while Australian interest rates may not be heading lower until next year, it could p...

Motley Fool AVH 2 months ago
August Health Winners: LTR Pharma, Control Bionics lead sector at the ‘cusp of an extraordinary era’

ASX health stocks down in August and trail the broader market in 2024 CSL up 6,000pc since listing; sector outpaced benchmark 10x since 2006 AI is revolutionising healthcare, boosting diagnosis and treatment   The ASX Healthcare Index (AS...

Stockhead AVH 3 months ago
Dicker Data share price crashes 9% on first-half earnings miss

The Dicker Data Ltd (ASX: DDR) share price is having a difficult finish to the week. In morning trade, the wholesale computer hardware and software distributor's shares are down 9.5% to $9.16. Investors have been hitting the sell button in...

Motley Fool AVH 3 months ago
ScoPo’s Powerplays: ASX health stocks rise as Pro Medicus again hit the ball out of the park”

ASX health stocks rise 0.8% past five days as broader market lifts 3.7%  Morgans says ProMedicus ‘produced yet another record result’ with net profit of $82.8m in FY24  CSL falls on FY24 results but Morgans still bullish on ASX’s largest h...

Stockhead AVH 4 months ago
The Overnight Report: More Fed Rate Cut Comfort

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin World Overnight SPI Overnight 7832.00 + 28.00 0.36% S&P ASX 200 7850.70 +...

FNArena AVH 4 months ago
The Overnight Report: US PPI, CBA Lift The Mood

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin World Overnight SPI Overnight 7829.00 + 59.00 0.76% S&P ASX 200 7826.80 +...

FNArena AVH 4 months ago
Big ASX news: The JB Hi-Fi share price just hit another new record high!

It's been a decent, if unspectacular, day for the S&P/ASX 200 Index (ASX: XJO) so far this Tuesday. At the time of writing, the ASX 200 has gained a tentative 0.18% and is up to just under 7,830 points. But the performance of the JB Hi-...

Motley Fool AVH 4 months ago
Broker says this ASX 100 share can deliver market-beating returns

The CAR Group Limited (ASX: CAR) share price had a strong start to the week on Monday. The ASX 100 share ended the session 4.5% higher at $35.14. Investors were buying the auto listings company's shares following the release of its full y...

Motley Fool AVH 4 months ago
The Overnight Report: Looking For Clues

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin World Overnight SPI Overnight 7762.00 + 3.00 0.04% S&P ASX 200 7813.70 + 3...

FNArena AVH 4 months ago
5 things to watch on the ASX 200 on Tuesday

On Monday, the S&P/ASX 200 Index (ASX: XJO) started the week in a positive fashion. The benchmark index rose 0.45% to 7,813.7 points. Will the market be able to build on this on Tuesday? Here are five things to watch: ASX 200 expected...

Motley Fool AVH 4 months ago
Here are the top 10 ASX 200 shares today

This Monday, the S&P/ASX 200 Index (ASX: XJO) and, by extension, many ASX shares had a stellar start to the trading week. After soaring on Friday, the ASX 200 kept up the momentu...

Motley Fool AVH 4 months ago
Up 7%: Why are ASX retail stocks rocketing today?

It's been a great start to the trading week this Monday for the S&P/ASX 200 Index (ASX: XJO) and many ASX shares by extension. At the time of writing, the ASX 200 has added a healthy 0.42%, pulling the index back up over 7,800 points. B...

Motley Fool AVH 4 months ago
Why Avita Medical, Car Group, Dicker Data, and JB Hi-Fi shares are soaring today

The S&P/ASX 200 Index (ASX: XJO) is on form again on Monday. At the time of writing, the benchmark index is up 0.5% to 7,818.1 points. Four ASX shares that are rising more than most today are listed below. Here's why they are pushing hi...

Motley Fool AVH 4 months ago
FNArena Corporate Results Monitor – 12-08-2024

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((AZJ)) - Auriz...

FNArena AVH 4 months ago
Dicker Data dividends: Here's what you need to know

Dicker Data Ltd (ASX: DDR) has kicked off the week with a positive start, announcing an 11 cents per share dividend before the market opened today. The announcement has driven DDR shares up 4% at the time of writing, with the stock now...

Motley Fool AVH 4 months ago
Car Group share price charging higher on 41% FY 2024 revenue surge

The CAR Group Ltd (ASX: CAR) share price is leaping higher today. Shares in the S&P/ASX 200 Index (ASX: XJO) auto listings company closed on Friday trading for $33.64. In morning trade on Monday, shares are changing hands for $34.92...

Motley Fool AVH 4 months ago
Weekly Ratings, Targets, Forecast Changes – 09-08-24

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Weekly update on stockbroker recommendation, target price, and earnings forecast cha...

FNArena AVH 4 months ago
Avita Medical share price spikes 10% as sales jump in Q2

The Avita Medical Ltd (ASX: AVH) share price is rallying hard on Friday, up 10% to trade at $14.82 at the time of writing. This follows the release of the company's financial results for the quarter ending 30 June 2024. For context,...

Motley Fool AVH 4 months ago
ASX Health Stocks: Neuren’s Angelman drug shows good results, but share price drops 7pc

Neuren shows promise in Angelman drug but shares down 7pc Avita aims for profitability by Q3 FY25 IDT lands $2.5-$4m mRNA contract with Sanofi   Neuren’s Angelman drug shows promise Market darling Neuren Pharmaceuticals (ASX:NEU) has just...

Stockhead AVH 4 months ago
The Overnight Report: Sunshine Friday

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Indications are the ASX is poised for a strong session today. World Overnight SP...

FNArena AVH 4 months ago
3 ASX Stocks to Watch in the Wake of the Recent Market Dip

Recent market trends have shown a notable downturn, marking the most significant decline since the disruptions experienced in 2022. While such volatility can create unease, it also presents opportunities to acquire high-quality stocks at at...

Kalkine Media AVH 4 months ago
July Health Winners: Oncosil, Zelira lead as ASX biotechs power through another strong month

S&P/ASX 200 Health Care index up 5pc in July, 9.5pc YTD Health sector gains momentum with expected Fed rate cuts; ResMed seen as a strong buy And ASX healthcare winners and losers in July   The S&P/ASX 200 Health Care index [XHJ]...

Stockhead AVH 4 months ago
ScoPo’s Powerplays: ASX health stocks rise despite Friday selloff, and what’s this – a potential cure for ageing?

ASX health stocks rise 0.9% in past five days as broader markets lift 1.2%, despite Friday selloff ImpediMed’s latest quarterly result shows sales momentum building for Sozo device  Cold-cathode X-ray machine developer MicroX makes progres...

Stockhead AVH 4 months ago
ASX Market Close: Records broken as bourse is bouyed by Wall Street rally | 1 August, 2024

The ASX200 hit a fresh record high and closed up around 0.3% at 8,115 points, as the 2024 Wall Street rally continues to buoy Australian sentiment. Almost all sectors were up, led by Real Estate up 1.7%, followed closely by Information T...

themarketonline.com.au AVH 4 months ago
2 popular ASX healthcare shares making news on Thursday

ASX healthcare shares have outperformed in the past 12 months. The broad index, represented by the S&P/ASX 200 Index (ASX: XJO), is up 10.5% in that time. Meanwhile, the S&P/ASX 200 Health Care Index (ASX: XHJ), a proxy for the l...

Motley Fool AVH 4 months ago
Top 10 at 11: Unlikely allies lead out ASX early on Thursday

Good morning, and welcome to Stockhead’s Top 10 at shortly-before-11-ish, which is meant to highlight the best (and sometimes worst) performing ASX stocks in morning trade using live data, to provide a short, sharp update to help frame the...

Stockhead AVH 4 months ago
Avita boosts skin restoration product portfolio with ‘dermal matrix’ – a kind of next-level gauze made of fake skin

Avita (ASX:AVH) has announced its development of a ‘dermal matrix’ – in other words, a kind of next-gen gauze made of a material closer to skin than cotton. The product’s development is being collaborated on with another entity called Re...

themarketonline.com.au AVH 4 months ago
Market Highlights: Nvidia, gold, oil all surge as Powell says time has come for a rate cut

The ASX s expected to rise after the Fed suggested a possible rate cut in September Nasdaq soared by 2.64pc, with Nvidia surging by 12pc Gold and oil prices also surged due to geopolitical tensions   The ASX200 index is expected to climb...

Stockhead AVH 4 months ago
ASX Market Open: US Fed keep rates on hold but September cut more likely | August 1

The ASX is set to rise a fifth of a percent on Thursday according to futures around 8.30am Sydney time. Overnight, the US Federal Reserve made its latest interest rate decision; keeping rates on hold but signalling a September cut is sti...

themarketonline.com.au AVH 4 months ago
Check Up: Europe delivers blow to Alzheimer’s research; and recent ASX health stock winners

The EMA has rejected the Alzheimer’s drug Leqembi, developed by Eisai and Biogen There is one ASX-listed company that collaborates with Eisai We take a look at the best performing ASX health stocks in the past month   In a major blow for...

Stockhead AVH 4 months ago
Want to buy ASX small-cap shares? The shot clock is running out

Australian investors have shown an interest in ASX small-cap shares in recent weeks amid a sharp correction in the broader markets. As we entered the new financial year, the S&P/ASX Small Ordinaries Index (ASX: XSO) rallied 4.6% to...

Motley Fool AVH 4 months ago